Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Russian Federation,France,Netherlands,Germany,Poland,Italy,Australia,Romania,Belgium,United Kingdom
nct
Update Il y a 5 ans
Open-Label Tolvaptan Study in Subjects With ADPKD
To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from baseline (from trial 156-04-251) in total kidney volume (TKV) and renal function.
Country
Argentina
,
Australia
,
Belgium
,
Canada
,
France
,
Germany
,
Italy
,
Netherlands
,
Poland
,
Romania
,
Russian Federation
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
Vicente Torres, MD, PhD
Update Il y a 5 ans
Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD
This study's purpose is to evaluate the long-term safety and efficacy of tolvaptan versus placebo in patients with ADPKD.
Country
Argentina
,
Australia
,
Belgium
,
Canada
,
Denmark
,
France
,
Germany
,
Italy
,
Japan
,
Netherlands
,
Poland
,
Romania
,
Russian Federation
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis
This study will assess the efficacy, safety, and tolerability of ACT-128800 in patients with relapsing-remitting multiple sclerosis.
Country
Australia
,
Austria
,
Belgium
,
Bulgaria
,
Canada
,
Czech Republic
,
Finland
,
France
,
Germany
,
Hungary
,
Israel
,
Italy
,
Netherlands
,
Poland
,
Romania
,
Russian Federation
,
Serbia
,
Spain
,
Sweden
,
Switzerland
,
Ukraine
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1